Trainer John

Chief Financial OfficerNexImmune, Inc. (NEXI) · full profile →Form 4 · filed Apr 6, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
10
0 non-derivative · 10 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 4, 2023Grant(A)14K14K
Apr 4, 2023Grant(A)89K89K
Apr 4, 2023Disposed to issuer(D)103K0
Apr 4, 2023Grant(A)10K10K
Apr 4, 2023Grant(A)89K$089K
Apr 4, 2023Disposed to issuer(D)29K0
Apr 4, 2023Grant(A)50K50K
Apr 4, 2023Grant(A)28K28K
Apr 4, 2023Disposed to issuer(D)78K0
Apr 4, 2023Grant(A)19K19K

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-023686) within minutes of acceptance. Every field above traces to the original document. Verify it directly: